The purpose of this article is to review the status and limitations of anatomic tumor response
metrics including the World Health Organization (WHO) criteria, the Response Evaluation …

OBJECTIVE. There is growing interest in using PET/CT for evaluating early response to
therapy in cancer treatment. Although widely available and convenient to use, standardized …

Since the 2003 guideline, several clinically relevant studies have been published, allowing
new recommendations regarding image guidance of pleural procedures with clear benefits …

Malignant pleural mesothelioma (MPM) is a rare tumour but with increasing incidence and a
poor prognosis. In 2008, the European Respiratory Society/European Society of Thoracic …

Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Abstract On March 28–29, 2017, the National Cancer Institute (NCI) Thoracic Malignacy
Steering Committee, International Association for the Study of Lung Cancer, and …

Introduction Malignant pleural mesothelioma poses unique difficulties in tumor
measurement and response assessment; however, robust and reproducible assessment of …

Purpose Metabolic tumor volume (MTV) and total lesion glycolysis (TLG) are measures of
metabolic activity of tumors determined by fluorine-18 fluorodeoxyglucose ([18 F] FDG) …

Background To evaluate the importance of assessing volume-based parameter of 18 F-FDG
PET/CT in patients with malignant pleural mesothelioma (MPM) for the prediction of …

Background Data from murine models suggest that CD40 activation may synergize with
cytotoxic chemotherapy. We aimed to determine the maximum tolerated dose (MTD) and …